Bayer recently reported its third-quarter 2025 results, highlighted by a 20.8% increase in adjusted operating income largely driven by its Crop Science division, as well as new late-breaking Phase III ...

We had a strong start to fiscal 2026 with Q1 revenue and earnings per share both coming in above the high end of our guidance ...